Marouf Hesham Mohamed
Department of Anesthesia and Surgical Intensive Care, Faculty of Medicine, Tanta University, Tanta, Egypt.
Anesth Essays Res. 2018 Jan-Mar;12(1):31-35. doi: 10.4103/aer.AER_223_17.
Emergence agitation (EA) is common in pediatrics after sevoflurane anesthesia.
We intended to study the effect of preoperative pregabalin on EA in pediatrics after sevoflurane anesthesia.
This study design was a prospective randomized controlled double-blinded study.
Sixty children with American Society of Anesthesiologists physical status Classes I-II, aged 4-10 years, prepared for adenotonsillectomy under sevoflurane anesthesia were randomized to two equal groups (control Group C and pregabalin Group P). Children received either placebo syrup (Group C) or pregabalin syrup 1.5 mg/kg (Group P) ½ h preoperatively. We recorded postoperative EA scale (EAS) (10, 20, and 30 min postoperatively), time to open the eye, time to extubate, postanesthesia care unit (PACU) duration of stay, number of paracetamol doses (15 mg/kg) given (to control postoperative pain), and complications as vomiting and dizziness on discharge.
Independent sample -test and Chi-square test were used as appropriate.
Pregabalin Group showed less EAS, less analgesic (paracetamol) requirement, and less vomiting with insignificant effects on time to open the eye or extubation and PACU duration of stay compared to control group.
Preoperative pregabalin decreased postoperative EAS, analgesic (paracetamol) requirement, and vomiting in pediatrics after adenotonsillectomy using sevoflurane anesthesia without affecting time to open the eye or extubation and PACU duration of stay.
七氟醚麻醉后小儿苏醒期躁动(EA)很常见。
我们旨在研究术前使用普瑞巴林对七氟醚麻醉后小儿EA的影响。
本研究设计为前瞻性随机对照双盲研究。
60例美国麻醉医师协会身体状况分级为I-II级、年龄4-10岁、准备在七氟醚麻醉下行腺样体扁桃体切除术的儿童被随机分为两组,每组30例(对照组C和普瑞巴林组P)。儿童在术前半小时分别接受安慰剂糖浆(C组)或1.5mg/kg普瑞巴林糖浆(P组)。我们记录了术后EA量表(EAS)(术后10、20和30分钟)、睁眼时间、拔管时间、麻醉后护理单元(PACU)停留时间、给予对乙酰氨基酚的剂量(15mg/kg)(以控制术后疼痛)以及出院时呕吐和头晕等并发症。
根据情况使用独立样本t检验和卡方检验。
与对照组相比,普瑞巴林组的EAS较低、镇痛(对乙酰氨基酚)需求较少、呕吐较少,对睁眼或拔管时间以及PACU停留时间无显著影响。
术前使用普瑞巴林可降低七氟醚麻醉下行腺样体扁桃体切除术后小儿的术后EAS、镇痛(对乙酰氨基酚)需求和呕吐发生率,且不影响睁眼或拔管时间以及PACU停留时间。